An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma.
MYCN
cancer cell of origin
cone precursor
dedifferentiation
retinoblastoma
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
12 07 2022
12 07 2022
Historique:
entrez:
22
7
2022
pubmed:
23
7
2022
medline:
27
7
2022
Statut:
ppublish
Résumé
Most retinoblastomas develop from maturing cone precursors in response to biallelic
Identifiants
pubmed: 35867756
doi: 10.1073/pnas.2200721119
pmc: PMC9282279
doi:
Substances chimiques
MYCN protein, human
0
N-Myc Proto-Oncogene Protein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2200721119Subventions
Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA137124
Pays : United States
Organisme : HHS | NIH | Center for Scientific Review (CSR)
ID : P30CA014089
Organisme : HHS | NIH | Center for Scientific Review (CSR)
ID : R01CA137124
Références
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33628-33638
pubmed: 33318192
EMBO J. 1999 Oct 1;18(19):5321-33
pubmed: 10508165
Sci Rep. 2016 Apr 29;6:25264
pubmed: 27126562
J Oncol. 2019 Apr 1;2019:6754040
pubmed: 31057614
Cancer Cell. 2012 May 15;21(5):601-613
pubmed: 22624711
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):731-6
pubmed: 15644444
Nat Rev Cancer. 2005 Aug;5(8):649-55
pubmed: 16056260
Cancer Discov. 2018 May;8(5):582-599
pubmed: 29510988
Nat Rev Cancer. 2017 Apr;17(4):239-253
pubmed: 28256574
Nat Commun. 2018 Mar 9;9(1):1024
pubmed: 29523784
Mol Cancer. 2006 Dec 12;5:72
pubmed: 17163992
Front Oncol. 2020 Dec 23;10:563156
pubmed: 33425720
Obstet Gynecol. 2017 May;129(5):e150-e154
pubmed: 28426621
Oncogene. 2017 Mar 30;36(13):1760-1769
pubmed: 27748758
Nature. 2014 Oct 16;514(7522):385-8
pubmed: 25252974
Cancer Discov. 2018 Feb;8(2):150-163
pubmed: 29358508
Oncogene. 2010 May 6;29(18):2681-90
pubmed: 20190806
Nat Rev Dis Primers. 2015 Aug 27;1:15021
pubmed: 27189421
Lancet Oncol. 2013 Apr;14(4):327-34
pubmed: 23498719
Biotechniques. 2020 Jun;68(6):349-352
pubmed: 32141762
Prog Retin Eye Res. 2019 Nov;73:100764
pubmed: 31173880
PLoS One. 2016 Apr 26;11(4):e0153323
pubmed: 27115612
Nat Genet. 2003 May;34(1):53-8
pubmed: 12692551
Oncol Res. 2017 Jan 26;25(2):167-176
pubmed: 28277188
Ophthalmic Genet. 2021 Jun;42(3):354-359
pubmed: 33870828
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9391-E9400
pubmed: 30213853
Genes Chromosomes Cancer. 2020 Oct;59(10):584-590
pubmed: 32390242
Mol Cancer Res. 2020 Dec;18(12):1825-1838
pubmed: 32661114
Cell Stem Cell. 2015 Jul 2;17(1):60-73
pubmed: 26095047
Cancers (Basel). 2020 Sep 22;12(9):
pubmed: 32971811
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5590-8
pubmed: 17122153
Nat Commun. 2021 Sep 22;12(1):5578
pubmed: 34552068
Cancer Res. 2012 Mar 1;72(5):1301-15
pubmed: 22246670
EBioMedicine. 2015 Jul 08;2(7):660-70
pubmed: 26288838
Cell. 2009 Jun 12;137(6):1018-31
pubmed: 19524506
J Comp Neurol. 2008 Sep 20;510(3):237-50
pubmed: 18626943
EBioMedicine. 2015 Jul 17;2(7):623-4
pubmed: 26288828
Cancer Med. 2017 Mar;6(3):619-630
pubmed: 28211617
Oncotarget. 2017 Nov 30;9(1):192-204
pubmed: 29416606
Hum Mol Genet. 2008 May 15;17(10):1363-72
pubmed: 18211953
Bioinformatics. 2017 Aug 01;33(15):2424-2426
pubmed: 28369169